Art. 3(a) SPC Regulation: An analysis of the CJEU’s ruling in Teva (C-121/17) and a proposal for its implementation

By Romandini R. On 25 July 2018, the Grand Chamber of the CJEU delivered the eagerly awaited decision on Art. 3(a) Regulation (EC) 469/2009, following the referral by Mr Justice Arnold in Teva (C-121/17).**** In answering the question of what it means to be protected by a basic patent under Art. 3(a) Reg. …read more

Source:: Journal of Intellectual Property Law & Practice